Hot Pursuit     15-Feb-17
Vivimed Labs in pink of health after strong Q3 result
Vivimed Labs surged 6.91% to Rs 103.70 at 9:51 IST on BSE after consolidated net profit spurted 124.63% to Rs 51.71 crore on 9.13% increase in net sales to Rs 360.03 crore in Q3 December 2016 over Q3 December 2015.
The result was announced after market hours yesterday, 14 February 2017.

Meanwhile, the S&P BSE Sensex was down 21.35 points, or 0.08%, to 28,317.96.

On the BSE, 5.39 lakh shares were traded on the counter so far as against the average daily volumes of 1.49 lakh shares in the past one quarter. The stock had hit a high of Rs 110.50 and a low of Rs 103 so far during the day.

The stock had hit a record high of Rs 121.15 on 4 October 2016 and a 52-week low of Rs 68 on 9 August 2016. The stock had underperformed the market over the past one month till 14 February 2017, declining 4.9% compared with the Sensex's 4.04% rise. The scrip had also underperformed the market over the past one quarter advancing 3.47% as against the Sensex's 5.67% rise.

The small-cap company has equity capital of Rs 16.20 crore. Face value per share is Rs 2.

Vivimed Labs is a niche specialty chemicals and pharmaceuticals company.

Previous News
  Vivimed Labs schedules board meeting
 ( Corporate News - 30-Jul-22   12:02 )
  Vivimed Labs AGM scheduled
 ( Corporate News - 19-Oct-23   15:55 )
  Vivimed Labs postpones board meeting
 ( Corporate News - 18-May-24   11:32 )
  Vivimed Labs receives EIR for API manufacturing facility at Cuernavaca, Mexico
 ( Corporate News - 05-Oct-18   10:49 )
  Vivimed Labs standalone net profit rises 1383.39% in the December 2016 quarter
 ( Results - Announcements 15-Feb-17   17:26 )
  Vivimed Labs to discuss results
 ( Corporate News - 20-Aug-20   18:24 )
  Vivimed Labs reports consolidated net loss of Rs 49.55 crore in the December 2020 quarter
 ( Results - Announcements 14-Feb-21   11:12 )
  Vivimed Labs consolidated net profit rises 809.99% in the March 2017 quarter
 ( Results - Announcements 14-Jun-17   15:56 )
  Vivimed Labs reports consolidated net loss of Rs 22.03 crore in the September 2022 quarter
 ( Results - Announcements 15-Nov-22   17:56 )
  Vivimed Labs to discuss results
 ( Corporate News - 29-Jul-23   12:54 )
  Vivimed Lab soars on first export shipment of famotidine tablets to Canada
 ( Hot Pursuit - 24-May-21   12:14 )
Other Stories
  UCO Bank’s total advances jump 19% YoY in Q2 FY25
  04-Oct-24   15:15
  Vakrangee Ltd leads losers in 'A' group
  04-Oct-24   15:00
  Kamdhenu Ventures Ltd leads losers in 'B' group
  04-Oct-24   14:45
  GRSE bags Rs 226-cr LoA from West Bengal Govt
  04-Oct-24   14:40
  Volumes soar at Avenue Supermarts Ltd counter
  04-Oct-24   14:30
  Real Estate stocks edge lower
  04-Oct-24   14:00
  Auto stocks edge lower
  04-Oct-24   14:00
  Utilties stocks edge lower
  04-Oct-24   14:00
  HDFC Bank Ltd down for fifth straight session
  04-Oct-24   13:35
  Power Grid Corporation of India Ltd down for fifth straight session
  04-Oct-24   13:35
Back Top